Vigil Neuroscience, Inc.
NASDAQ:VIGL
2.42 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -84.256 | -82.638 | -68.305 | -43.283 | -28.546 |
| Depreciation & Amortization
| 0.453 | 0.399 | 0.078 | 0.028 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 10.117 | 8.903 | 5.477 | 2.085 | 0.001 |
| Change In Working Capital
| 22.618 | 3.098 | -3.331 | 0.642 | 0.85 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.021 | 0.005 | -2.478 | 2.35 | 1.107 |
| Other Working Capital
| 22.597 | 3.093 | -0.853 | -1.708 | -0.257 |
| Other Non Cash Items
| -0.155 | -0.125 | 0.932 | 1.181 | 21.409 |
| Operating Cash Flow
| -51.223 | -70.363 | -65.149 | -39.347 | -5.18 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.005 | -0.674 | -0.921 | -0.204 | -0.5 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -80.852 | -147.468 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 89.617 | 83.004 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | -0.001 |
| Investing Cash Flow
| 8.76 | -65.138 | -0.921 | -0.204 | -0.5 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | -0.023 | -0.043 | -0.038 | 0 |
| Common Stock Issued
| 9.542 | 0.911 | 140.466 | 19.879 | 24.831 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 19.948 | 0.911 | 20.832 | 107.785 | 29.831 |
| Financing Cash Flow
| 29.49 | 0.888 | 161.255 | 107.747 | 29.831 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -12.973 | -134.613 | 95.185 | 68.196 | 24.151 |
| Cash At End Of Period
| 39.946 | 51.992 | 187.532 | 92.347 | 24.151 |